RT Journal Article
SR Electronic
T1 1359 NTX-0471, engineered multivalent SIRPa and bispecific SIRPa-antiCCR4 molecules demonstrate superior activity providing path for mRNA expressed <em>in-vivo</em> biologics
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1514
OP A1515
DO 10.1136/jitc-2023-SITC2023.1359
VO 11
IS Suppl 1
A1 Kannan, Gunasekaran
A1 Sallets, Adrienne
A1 Adusumilli, Gowrisudha
A1 Bandi, Srinivasa
A1 Lal, Shruti
A1 Low, Ray
A1 Liu, Weiqun
A1 Haabeth, Ole Audun
A1 McKinlay, Colin
A1 Hsu, Pei-Ken
A1 Ferry, Kimmy
A1 Sharma, Anustha
A1 Triplett, Jenna
A1 Leong, Meredith
A1 McCartney-Melstad, Evan
A1 Deutsch, Samuel
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1514.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.